Expression of wild-type estrogen receptor β and variant isoforms in human breast cancer

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5425-5428

  Fuqua, Suzanne A W ^a   Schiff, Rachel ^a   Parra, Irma ^a   Friedrichs, William E ^a   Su, Jui Lan ^b   McKee, David D ^b   Slentz Kesler, Kimberly ^b   Moore, Linda B ^b   Willson, Timothy M ^b   Moore, John T ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

BLOTTING, WESTERN; BREAST NEOPLASMS; DNA, COMPLEMENTARY; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSTEOSARCOMA; PHENOTYPE; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033230504     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McGuire, W. L., Carbone, P. P., and Vollmer, E. P. (eds.). Estrogen Receptors in Human Breast Cancer. New York: Raven Press, 1975.
2. Dickson, R. B., and Lippman, M. E. Cellular and molecular biology. In: M. E. Lippman, and R. B. Dickson (eds.), Breast Cancer, pp. 119-165. Norwell, MA: Kluwer Academic Publishers, 1998.
3. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., and Chambon, P. Human estrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (Lond.), 320: 134-139, 1986.
4. Pujol, P., Rey, J. M., Nirde, P., Pascal, R., Gastaldi, M., Faffargue, F., Rochefort, H., and Maudelonde, T. Differential expression of estrogen receptor-α and -β messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res., 58: 5367-5373, 1998.
5. Leygue, E., Dotzlaw, H., Watson, P. H., and Murphy, L. C. Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res., 58: 3197-3201, 1998.
6. Mosselman, S., Polman, J., and Dijkema, R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392: 49-53, 1996.
7. Ogawa, S., Inoue, S., Watanabe, T., Hiroi, H., Orimo, A., Hosoi, T., Ouchi, Y., and Muramatsu, M. The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerization with ERα in vivo and in vitro. Biochem. Biophys. Res. Commun., 243: 122-126, 1998.
8. Moore, J. T., McKee, D. D., Slentz-Kesler, K., Moore, L., Jones, S., Horne, E., Su, J-L., Kliewer, S. A., Lehmann, J. M., and Willson, T. M. Cloning and characterization of human estrogen receptor β isoforms. Biochem. Biophys. Res. Commun., 247; 75-78. 1998.
9. Maruyama, K., Endoh, H., Sasaki-Iwaoka, H., Kanou, H., Shimaya, E., Hashimoto, S., Kato, S., and Kawashima, H. A novel isoform of rat estrogen receptor β with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regulator of estrogen action. Biochem. Biophys. Res. Commun., 246: 142-147, 1998.
10. Fuqua, S. A. W., Allred, D. C., Elledge, R. M., Krieg, S. L., Benedix, M. G., Nawaz, Z., O'Malley, B. W., Greene, G. L., and McGuire, W. L. The estrogen receptor positive/progesterone receptor negative breast cancer phenotype is not associated with mutations within the ER DNA binding domain. Breast Cancer Res. Treat., 26: 191-202, 1993.
11. Kuiper, G. G. J. M., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA, 93: 5925-5930, 1996.
12. Ogawa, S., Inoue, S., Watanabe, T., Orimo, A., Hosoi, T., Ouchi, Y., and Muramatsu, M. Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res., 26: 3505-3512, 1998.
13. Su, J-L., Stimpson, S., Edwards, E. D., Van Arnold, J., Burgess, S., and Peiyuan, L. Neutralizing IGF-1 monoclonal antibody with cross-species reactivity. Hybridoma, 16: 513-518, 1997.
14. Leygue, E., Dotzlaw, H., Watson, P. H., and Murphy, L. C. Expression of estrogen receptor β1, β2, and β5 messenger RNAs in human breast tissue. Cancer Res., 59: 1175-1179, 1999.
15. Peache, K., Webb, P., Kuiuper, G. G. J. M., Nillson, S., Gustaffson, J. A., Kushner, P. J., and Scanlon, T. S. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science, (Washington DC), 277: 1508-1510, 1998.
16. Tora, L., Gronemeyer, H., Turcotte, B., Gaub, M. P., and Chambon, P. The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature (Lond.), 333: 185-188, 1988.
17. Bhat, R. A., Harnish, D. C., Stevis, P. E., Lyttle, C. R., and Kromm, B. S. A novel human estrogen receptor β: identification and functional analysis of additional N-terminal amino acids. J. Steroid Biochem. Mol. Biol., 67: 233-240, 1998.
18. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. Expression of estrogen receptor-β in human breast tumors. J. Clin. Endocrinol. Metab., 82: 2371-2374, 1996.
19. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. Estrogen receptor-β messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res., 59: 529-532, 1999.
20. Vladusic, E. A., Hornby, A. E., Guerra-Vladusic, F. K., and Lupu, R. Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res., 58: 210-214, 1998.